GRI: Multiplikator rega marang pendapatan GRI Bio Corp
GRI Bio, Inc. (GRI) is actively developing NKT cell modulators for the therapy of organ fibrosis. This GURU.Markets terminal chart of historical P/S dynamics reflects market sentiment, with the metric fixed at 0.00. Patents and the success of the GRI-0621 candidate are driving the stock's growth. Future profits are expected from the implementation of high-cost innovations for insurance funds and medical centers.
Rincian analitis perusahaan GRI Bio Corp (GRI)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- data kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi GRI Bio, Inc.|GRI - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas GRI Bio Corporation|GRI - Gunggung utang perusahaan|Utang-utang marang aset resik GRI Bio Corp|GRI - Utang jangka dawa perusahaan|Utang jangka cendhak GRI Bio|Rasio jangkoan perantara gribio.com
- informasi bathi lan kelipatan valuasi:
GRI - Bathi resik|Prakiraan bathi perusahaan GRI Bio, Inc.|GRI - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep GRI Bio Inc|GRI - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GRI Bio Corp|GRI - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan GRI Bio|GRI - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku gribio.com|GRI - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep GRI Bio, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:GRI, gribio.com
GRI Bio, Inc. is developing innovative immunology amidst geopolitical barriers that complicate biomaterial logistics and slow down global drug certification. The market capitalization-to-sales ratio allows for an assessment of the fundamental link between the share price and actual revenue, while the price/sales ratio trend helps investors timely recognize asset overbought conditions or the risk of capital freeze in a weakening business.
Pesaing GRI Bio, Inc.
ARGX - Rega marang dodolan|Multiplikator P/S BNTX (BioNTech)|Multiplikator rega marang pendapatan Abivax Pharma|ADMA - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PTGX (Protagonist Corp)|IMVT: Multiplikator P/S|KNSA - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan GRFS|ADPT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S CLDX|Rasio rega marang pendapatan AUPH (Aurinia Corp)|Multiplikator P/S BCRX (BioCryst)|Koefisien rega marang pendapatan veratx.com (VERA)|DNTH - Rasio rega marang pendapatan|Rega marang dodolan Pharvaris NV|ABCL (AbCellera Biologics Inc) - Kapitalisasi marang pendapatan|Tourmaline - Rasio kapitalisasi pasar marang pendapatan|PGEN (Precigen, Inc.) - Multiplikator P/S|pharming.com (PHAR) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Nektar Therapeutics Inc. (NKTR)|Upstream Bio, Inc. - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ZBIO (Zenas Biopharma, Inc.)|IMNM - Kapitalisasi marang pendapatan|GOSS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan kalvista.com KALV|SEPN: Multiplikator P/S|Multiplikator rega marang pendapatan Pieris Pharma PVLA|Rasio rega marang pendapatan Savara Corp|RIGL: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ANAB|Koefisien rega marang pendapatan astriatx.com|Rasio rega marang pendapatan enGene ENGN|RAPT (RAPT Therapeutics Inc.) - Rasio rega marang dodolan|Aerovate - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACRS (Aclaris Therapeutics, Inc)|KYTX: Multiplikator P/S|tizianalifesciences.com (TLSA) - Multiplikator P/S|Rasio rega marang pendapatan Cabaletta Bio|VTYX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Theratechnologies Inc (THTX)|Kapitalisasi marang pendapatan Avalo Therapeutics Inc AVTX|Multiplikator P/S ELDN (Eledon Pharmaceuticals)|Multiplikator P/S agenusbio.com AGEN|CLYM: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ZURA (Zura Bio Ltd)|ATYR: Multiplikator P/S|ADAG - Koefisien rega marang pendapatan|Rasio rega marang pendapatan ImageneBio|Kapitalisasi marang pendapatan Shattuck Therapeutics (STTK)|Rasio rega marang pendapatan Equillium, Inc. (EQ)|Kapitalisasi marang pendapatan connectbiopharm.com CNTB|Immunic - Kapitalisasi marang pendapatan|Multiplikator P/S Atara Biotherapeutics, Inc. ATRA|IFRX - Rasio rega marang pendapatan|XFOR (x4pharma.com) - Rasio kapitalisasi marang pendapatan|ACET: Multiplikator P/S|Rega marang dodolan Celularity (CELU)|INMB (INmune Bio Corp) - Multiplikator P/S|BRNS - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AKTX (Akari Therapeutics Plc)|Koefisien rega marang pendapatan Enlivex Therapeutics Ltd (ENLV)|QTTB: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan GOVX (GeoVax Corp)|EDSA: Multiplikator P/S|IBIO (ibioinc.com) - Rasio rega marang pendapatan|CARM (Carisma Therapeutics Inc) - Multiplikator P/S|XTL Biopharmaceuticals Ltd (XTLB) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Bolt Biotherapeutics (BOLT)|HCWB - Rega marang dodolan|Aptevo Therapeutics Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan AIM|Aditxt Corp - Multiplikator P/S|Koefisien rega marang pendapatan XORTX Therapeutics Inc XRTX|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan REVB|INDP (Indaptus Therapeutics) - Multiplikator P/S|Kapitalisasi marang pendapatan scinai.com (SCNI)|Kapitalisasi marang pendapatan CALI (CalciMedica, Inc.)|Koefisien rega marang pendapatan affimed.com|Multiplikator P/S ALLK (Allakos)|Multiplikator rega marang pendapatan HOOKIPA Pharma, Inc.|IGMS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iteostherapeutics.com)|OCEA: Multiplikator P/S|TCBP - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Third Harmonic Bio, Inc
